Latest Breaking News On - Sari fishman - Page 1 : comparemela.com

Can-Fite to Participate in Partnering Meetings at Bio International Convention 2024

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announces that its VP of Business.

San diegoUnited statesSari fishmanBio international conventionFite biopharma ltdBusiness developmentDrug administrationCan fite biopharmaNorth americaFite biopharmaOrphan drug designationFast track designationAnnual report

Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference Seite 1

11.03.2024 - Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology and inflammatory diseases, today announced its VP of Business Development, Dr. Sari . Seite 1

Sari fishmanVp business development at canBio europe conferenceNamodenoson treatment for pancreatic and liver cancer

Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference -March 11, 2024 at 07:06 am EDT

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology and inflammatory diseases, today announced its VP of Business.

South koreaComunidad autonoma de catalunaUnited statesGebro pharmaSari fishmanDrug administrationVp business development at canBusiness developmentFite biopharma ltdCan fite biopharmaEurope springBio europe conferenceFite biopharmaOrphan drug designationFast track designationAnnual report

Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced that it has expanded.

United statesSari fishmanFite vp business development drFite biopharma ltdDrug administrationCan fite biopharmaSwitzerland based ewopharmaCentral eastern europeanCentral eastern europeFite biopharmaOrphan drug designationFast track designationAnnual report

Can-Fite BioPharma Ltd : Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication

Can-Fite BioPharma Ltd : Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSari fishmanStefan klotterFite biopharmaMotti farbsteinFite biopharma ltdDrug administrationFite vp business development drCan fite biopharmaSwitzerland based ewopharmaCentral eastern europeanCentral eastern europeOrphan drug designationFast track designationAnnual reportDie performance strategie